The potential role of BTMs in the prediction of hypocalcemia induced by denosumab in patients with bone metastases.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2016
At a glance
- Drugs Denosumab (Primary)
- Indications Bone metastases
- Focus Adverse reactions; Pharmacodynamics
- 20 Jun 2016 New trial record